“Role of Dapagliflozin in the Management of Body Mass Index (BMI) and Glycated Hemoglobin (Hba1c) in Obese Type 2 Diabetic Patients”. Medical Forum Monthly 33, no. 12 (January 4, 2023). Accessed October 13, 2026. http://medicalforummonthly.com/index.php/mfm/article/view/1453.